“eli-lilly” Archives

in
Entry Author Date Location
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
Eli Lilly Pledges $52M to Life Sciences Partnership with Purdue 07/06/17 Indiana
Alder Drug Cuts Down Migraines in Study, But Still Trails Rivals 06/27/17 Seattle
Lilly Adds Chemistry Capabilities in San Diego Lab Expansion 06/22/17 San Diego
Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs 06/14/17 New York
Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More 06/09/17 National
Eli Lilly Fronts $55M for Rights to KeyBioscience’s Diabetes Drugs 06/08/17 Indiana
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Array Lands $31M in Licensing Deal with Japan’s Ono Pharma 06/01/17 Boulder/Denver
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More 05/05/17 National
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Radius Nabs FDA OK For New Bone Drug With Rival Amgen Close Behind 04/28/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment 04/20/17 Texas
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
FDA Nixes Lilly, Incyte RA Drug, Seeks More Dosing and Safety Data 04/14/17 Indiana
IBRI, Dow Agrosciences, Lilly Partner on Molecular Safety Database  03/28/17 Indiana
Eli Lilly Reveals $850M Capital Spending Plan for Indiana and Beyond 03/24/17 Indiana
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
BioCrossroads Report: Steady Growth for Life Sciences in Indiana 02/24/17 Indiana
Xenex Gets $38M From Essex Woodlands, Others for Germ-Zapping Robots 02/24/17 Texas
Merck Alzheimer Drug Is Latest To Fail In A Big Study 02/15/17 National
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Bayer Enlists Trana Discovery to Find New Fungicides for Field Crops 02/08/17 Raleigh Durham
With Another Migraine Drug Bet, Lilly Snaps Up CoLucid For $960M 01/18/17 Indiana
Anthera’s Shares Tumble After Cystic Fibrosis Drug Fails in Phase 3 12/28/16 San Francisco
Page 2 of 15 « previous page · next page »